PAREXEL Forms Collaboration With Clinical Research Services Provider in India
PAREXEL International Corporation announced that it has entered into an exclusive strategic collaboration with Synchron Research services Private Limited, a privately held contract research organization headquartered in Ahmedabad, India. Founded in 1998, Synchron provides a broad range of Phase I-IV clinical research services including regulatory affairs, quality assurance, statistical analysis and data management capabilities. Synchron's facility also includes a 36-bed clinical pharmacology research unit for the conduct of bioequivalence, bioavailability and pharmacokinetic studies and a bioanalytical laboratory. Terms of the agreement were not disclosed.
Under the alliance, PAREXEL will leverage Synchron's capabilities to benefit bio/pharmaceutical clients with expanded geographic coverage and patient recruitment capabilities in India and Bangalore. The alliance also provides Synchron's customers with access to the clinical trial expertise, advanced technologies, and project management skills of PAREXEL, one of the world's largest bio/pharmaceutical outsourcing providers.
"The collaboration with Synchron expands our global clinical research services into regions that should help expedite the drug development process for our clients," said Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer. "Our alliance with an established company headquartered in India underscores PAREXEL's commitment to providing clients with comprehensive drug development services in emerging markets."
"Through our alliance with PAREXEL, we can now offer clients an extensive portfolio of clinical development solutions," stated Dr. Shivprakash, Ph.D., Chief Executive Officer, Synchron Research. "Our synergistic approach provides clients with enhanced clinical capabilities and strategies, enabling them to accelerate crucial time to market."
Other news from the department business & finance
